Zobrazeno 1 - 10
of 282
pro vyhledávání: '"J, Bichel"'
Autor:
J. Bichel-Findlay
While health and care are increasingly delivered in a digital world, the digital community continues to explore the transformative potential of artificial intelligence and machine learning. In this rapidly developing environment, it is acknowledged t
Science-fiction author William Gibson is famously quoted as saying, “The future is already here – it's just not very evenly distributed.” During the Covid pandemic, telehealth and remote monitoring were elevated from interesting innovations to
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Acta Pharmacologica et Toxicologica. 26:41-45
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c353ec213f24b8f6425555ad805d6f1f
https://doi.org/10.1111/j.1600-0773.1967.tb00425.x
https://doi.org/10.1111/j.1600-0773.1967.tb00425.x
Publikováno v:
British Journal of Dermatology. 157:41-46
Summary Objective In the USA, Imiquimod 5% cream is approved for use 2–3 times per week over 16 weeks for the treatment of actinic keratoses (AKs). This study evaluated the efficacy of imiquimod in another treatment schedule, for AKs on the head. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::485fbf2c39ae562454a870d61dcdd93c
https://doi.org/10.1111/j.1365-2133.2007.08272.x
https://doi.org/10.1111/j.1365-2133.2007.08272.x
Autor:
B. Guidi, Sylvie Euvrard, P. Amerio, Claas Ulrich, P.C.M. van de Kerkhof, H.B. Slade, J. Ronnevig, J. Bichel, Eggert Stockfleth, Charlotte M. Proby
Publikováno v:
British Journal of Dermatology, 157 Suppl, 25-31
British Journal of Dermatology, 157 Suppl, 2, pp. 25-31
British Journal of Dermatology, 157 Suppl, 2, pp. 25-31
Contains fulltext : 52631.pdf (Publisher’s version ) (Closed access) OBJECTIVE: In this study the safety and efficacy of imiquimod 5% cream for the treatments of actinic keratoses in kidney, heart and liver transplant recipients is evaluated. BACKG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dffb6c8c5d3d772d5b8892f0e92dc57
https://hdl.handle.net/2066/52631
https://hdl.handle.net/2066/52631
Publikováno v:
Der Hautarzt. 52:812-816
Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal form of junctional epidermolysis bullosa. The expression of type XVII collagen (180 kDa bullous pemphigoid antigen) or of laminin 5 is markedly reduced in the skin. A 13-year-ol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8611438a9ab827d2b74d664b3d973171
https://doi.org/10.1007/s001050170072
https://doi.org/10.1007/s001050170072
Autor:
J, BICHEL
Publikováno v:
Acta pathologica et microbiologica Scandinavica. 22(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c7db35e7e9ad56155275727f1b9b1696
https://pubmed.ncbi.nlm.nih.gov/21021818
https://pubmed.ncbi.nlm.nih.gov/21021818
Publikováno v:
The British journal of dermatology. 157
In the USA, Imiquimod 5% cream is approved for use 2-3 times per week over 16 weeks for the treatment of actinic keratoses (AKs). This study evaluated the efficacy of imiquimod in another treatment schedule, for AKs on the head.Open-label, phase IIIb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::647cb2917cc41a1074c44b34e492d182
https://pubmed.ncbi.nlm.nih.gov/18067631
https://pubmed.ncbi.nlm.nih.gov/18067631